Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Leases: 2019-2024

Historic Current Leases for Cumberland Pharmaceuticals (CPIX) over the last 6 years, with Dec 2024 value amounting to $356,508.

  • Cumberland Pharmaceuticals' Current Leases rose 2.49% to $401,445 in Q3 2025 from the same period last year, while for Sep 2025 it was $401,445, marking a year-over-year increase of 2.49%. This contributed to the annual value of $356,508 for FY2024, which is 2.42% up from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Current Leases stood at $356,508, which was up 2.42% from $348,092 recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Current Leases ranged from a high of $1.0 million in FY2020 and a low of $172,910 during FY2022.
  • In the last 3 years, Cumberland Pharmaceuticals' Current Leases had a median value of $348,092 in 2023 and averaged $292,503.
  • In the last 5 years, Cumberland Pharmaceuticals' Current Leases plummeted by 82.17% in 2022 and then skyrocketed by 101.31% in 2023.
  • Cumberland Pharmaceuticals' Current Leases (Yearly) stood at $1.0 million in 2020, then fell by 4.63% to $969,677 in 2021, then crashed by 82.17% to $172,910 in 2022, then soared by 101.31% to $348,092 in 2023, then grew by 2.42% to $356,508 in 2024.